BIIO (Bionovate Technologies) Total Liabilities: $0.53 Mil (As of Sep. 2021)


What is Bionovate Technologies Total Liabilities?

Bionovate Technologies BIIO Total Liabilities is $0.53 Mil as of Sep. 2021.

Bionovate Technologies's Total Liabilities for the quarter that ended in Sep. 2021 was $0.53 Mil.

Bionovate Technologies's quarterly Total Liabilities increased from Mar. 2021 ($0.48 Mil) to Jun. 2021 ($0.50 Mil) and increased from Jun. 2021 ($0.50 Mil) to Sep. 2021 ($0.53 Mil).

Bionovate Technologies's annual Total Liabilities increased from Jun. 2019 ($0.33 Mil) to Jun. 2020 ($0.40 Mil) and increased from Jun. 2020 ($0.40 Mil) to Jun. 2021 ($0.50 Mil).

Bionovate Technologies Total Liabilities Historical Data

* Premium members only.

The historical data trend for Bionovate Technologies's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionovate Technologies Total Liabilities Chart

Bionovate Technologies Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Total Liabilities
Get a 7-Day Free Trial Premium Member Only 0.23 0.31 0.33 0.40 0.50

Bionovate Technologies Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.42 0.45 0.48 0.50 0.53

Bionovate Technologies Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Bionovate Technologies's Total Liabilities for the fiscal year that ended in Jun. 2021 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.503+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.50

Total Liabilities=Total Assets (A: Jun. 2021 )-Total Equity (A: Jun. 2021 )
=N/A--0.503
=N/A

Bionovate Technologies's Total Liabilities for the quarter that ended in Sep. 2021 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.525+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.53

Total Liabilities=Total Assets (Q: Sep. 2021 )-Total Equity (Q: Sep. 2021 )
=N/A--0.525
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $0.53 Mil mean?
Bionovate Technologies (BIIO) has a Total Liabilities of $0.53 Mil as of Sep. 2021. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Bionovate Technologies and its competitors.
Is Bionovate Technologies' Total Liabilities too high?
Bionovate Technologies' current Total Liabilities is $0.53 Mil.
How does Bionovate Technologies' Total Liabilities compare to ABT and MDT?
Bionovate Technologies' Total Liabilities of $0.53 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Bionovate Technologies and its competitors. Bionovate Technologies's current Total Liabilities is $0.53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bionovate Technologies stock overvalued right now?
Bionovate Technologies (BIIO) has a current Total Liabilities of $0.53 Mil. The current Total Liabilities is $0.53 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Bionovate Technologies (BIIO), the current Total Liabilities is $0.53 Mil as of Sep. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bionovate Technologies Business Description

Address 950 W Bannock Street, Boise, ID, USA, 83702
Bionovate Technologies Corp operates in the medical devices and diagnostics sector with a focus on mobile technologies.